← BackEarth Science Tech, Inc. · DrugmakersETST
Low riskNext report: Around Dec 5 (est.)
The short versionA profitable company with steady sales.
Going well
- Profitable
- Brings in more cash than it spends
- No debt reported
Watch out for
- Share count growing 26.2% a year (dilution)
Money moves
- No insider buying or selling in the last 30 days
Facts from SEC filings, not a recommendation.
The business over time
Last 12 quarters, from SEC filings
Sales, Jun '26$9.0M+3.0% vs a year earlier
Sep '23Tap a barJun '26
Last 12 months: $36.0M, up 8.0% from the 12 months before.
Business quality
The checklist Warren Buffett-style investors use. Annual numbers for 2025.- PassReturn on equity 15%+Earns a lot on the money owners have in the business.101.8%
- PassDebt under half of equityNot relying on borrowed money.No debt reported
- PassNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.10.2%
- MissProfitable every yearSteady profits, not one good year.4 of 9 years
- PassFree cash flow positiveBrings in more cash than it spends to run and grow.$1.2M
- MissShare count not growingNot diluting owners. Falling means buybacks.+100.9% in 3 years
- PassGross margin 40%+Pricing power: sells for well above what it costs to make.71.4%
- Revenue
- $35.7M
- +7.8% vs prior year
- Total debt
- None
- 0.00x equity
- Current ratio
- 1.34x
- short-term assets / bills due
- Free cash flow
- $1.2M
- 3.3% of revenue
From annual reports filed with the SEC. A checklist is a starting point for research, not a verdict.
Latest quarter
Quarter ended Jun 30, 2026- Revenue
- $9.0M
- +3.0% YoY
- EPS
- $0.00
- vs $0.00
- Gross margin
- 69.5%
- 0.0 pts
- Free cash flow
- $666K
- Share count
- -1.5%
- vs a year ago
Insider rating
Last 90 days
No open-market insider buys or sells in the last 90 days.
Weekly insider trendNo trades to chart yet.
Filing buzz
Last 7 days vs normal
67/ 100
- This week
- 1
- Normal week
- 0.5
- vs normal
- 2.0x
SEC filings of any kind. 50 means a normal week.
Share count growthYearly rate, last 3 years
-2.9%Cash runwayAt last year's cash burn
Cash flow positiveDebt to equityLatest balance sheet: debt compared with what owners have
No debt reportedShares outstandingLatest reported
288MNext reportAround Dec 5 (est.)Estimated from the same quarter last year
- Results filedAug 7
- Results filedJun 18
- Results filedJun 27, 2025
- Results filedJun 20, 2023
Insider trades
Open-market buys and sells, last 90 days
No open-market buys or sells in 90 days. Grants and option exercises are left out.
"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.